Clinical Trials
2 trialsNCT00064142 2013-06-05
Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00027677 2012-07-24
Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1 Completed